ID
14828
Beschrijving
Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane; ODM derived from: https://clinicaltrials.gov/show/NCT00036270
Link
https://clinicaltrials.gov/show/NCT00036270
Trefwoorden
Versies (1)
- 01-05-16 01-05-16 -
Geüploaded op
1 mei 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Neoplasms NCT00036270
Eligibility Breast Neoplasms NCT00036270
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
ID.3
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0038894
- UMLS CUI [1,2]
- C1276305
Beschrijving
ID.4
Datatype
boolean
Alias
- UMLS CUI [1]
- C0278601
Beschrijving
ID.5
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0229730
- UMLS CUI [1,2]
- C0019638
Beschrijving
ID.6
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0027627
- UMLS CUI [1,2]
- C1123023
- UMLS CUI [1,3]
- C0041582
- UMLS CUI [1,4]
- C0332448
Beschrijving
ID.7
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0600558
- UMLS CUI [1,2]
- C3665472
Beschrijving
ID.8
Datatype
boolean
Alias
- UMLS CUI [1]
- C0007124
- UMLS CUI [2]
- C0279563
Beschrijving
ID.9
Datatype
boolean
Alias
- UMLS CUI [1]
- C2919271
- UMLS CUI [2]
- C2919590
Similar models
Eligibility Breast Neoplasms NCT00036270
- StudyEvent: Eligibility
C0679557 (UMLS CUI [1,2])
C0728940 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C0392920 (UMLS CUI [4])
C1276305 (UMLS CUI [1,2])
C0019638 (UMLS CUI [1,2])
C1123023 (UMLS CUI [1,2])
C0041582 (UMLS CUI [1,3])
C0332448 (UMLS CUI [1,4])
C3665472 (UMLS CUI [1,2])
C0279563 (UMLS CUI [2])
C2919590 (UMLS CUI [2])